These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5374022)

  • 1. Immunogenic fragment antigens from tissue cultures infected with the virus of louping-ill (arbovirus group B).
    Brotherston JG; Boyce JB
    J Gen Microbiol; 1969 Dec; 59(3):i. PubMed ID: 5374022
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in the haemagglutinin content of crude mouse brain antigens containing louping ill virus.
    Timoney PJ
    Res Vet Sci; 1971 Sep; 12(5):490-1. PubMed ID: 5107106
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic and immunogenic properties of Langat TP-21 virus.
    Smorodintsev AA; Ilyenko VI; Platonov VG
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():132-7. PubMed ID: 4968626
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of nucleic acids and antigens in tissue culture cells doubly infected with measles and tick-borne encephalitis viruses, as revealed by fluorescence microscopy.
    Parfanovich MI; Sokolov NN
    Acta Virol; 1965 Jul; 9(4):352-7. PubMed ID: 4159903
    [No Abstract]   [Full Text] [Related]  

  • 5. Propagation of tick-borne encephalitis virus variants in short-term cultures of normal human leukocytes.
    Mayer V; Dobrocká E
    Acta Virol; 1969 Sep; 13(5):435-8. PubMed ID: 4398708
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression in toxoplasmosis: studies in sheep with vaccines for chlamydial abortion and louping-ill virus.
    Buxton D; Reid HW; Finlayson J; Pow I; Anderson I
    Vet Rec; 1981 Dec; 109(25-26):559-61. PubMed ID: 6278695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of sheep to louping-ill virus vaccine.
    Shaw B; Reid HW
    Vet Rec; 1981 Dec; 109(24):529-31. PubMed ID: 6280367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precipitating antigens of the tick-borne encephalitis group extracted from tissue culture].
    Kokorev VS; Eakirova SF
    Vopr Virusol; 1966; 11(3):357-62. PubMed ID: 6002858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of purification and inactivation of brain tissue culture preparations of tick-borne encephalitis virus on its antigenic and immunogenic components].
    Nawrocka E; Bednarz K
    Med Dosw Mikrobiol; 1980; 32(1):43-53. PubMed ID: 7412444
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the double immunodiffusion test for the diagnosis of louping ill infection.
    Timoney PJ
    Res Vet Sci; 1980 Mar; 28(2):195-8. PubMed ID: 6251524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic similarity of central European encephalitis and louping-ill viruses.
    Hubálek Z; Pow I; Reid HW; Hussain MH
    Acta Virol; 1995 Dec; 39(5-6):251-6. PubMed ID: 8722293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a non-infective protective antigen against louping-ill (arbovirus group B). Laboratory experiments.
    Brotherston JG; Boyce JB
    J Comp Pathol; 1970 Jul; 80(3):377-88. PubMed ID: 5529405
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of the hemagglutinating activity of the Russian tick-borne encephalitis virus complex under conditions of incubation in primary and transplantable (BHK-21) cultures of Syrian hamster kidney cells].
    Tkachenko EA; Chumakov MP
    Vopr Virusol; 1968; 13(4):433-6. PubMed ID: 5750399
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro cultivation studies on the Skalica strain of tick-borne encephalitis virus.
    Gresíková M; Sekeyová M
    Acta Virol; 1980 Dec; 24(6):455-8. PubMed ID: 6111207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serological response and long-lasting resistance against infection with louping-ill virus in sheep immunized with a highly attenuated tick-borne encephalitis virus.
    Mayer V; Blaskovic D; Ernek E; Libíková H
    J Hyg (Lond); 1969 Dec; 67(4):731-8. PubMed ID: 4982559
    [No Abstract]   [Full Text] [Related]  

  • 16. Field trials of an inactivated oil-adjuvant vaccine against louping-ill (Arbovirus group B).
    Brotherston JG; Bannatyne CC; Mathieson AO; Nicolson TB
    J Hyg (Lond); 1971 Sep; 69(3):479-89. PubMed ID: 5285947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response of sheep following administration of louping-ill virus vaccine.
    Reid HW; Pow I
    Vet Rec; 1995 Jun; 136(25):638-9. PubMed ID: 7571273
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranuclear inclusion bodies in the brain of guinea-pigs infected with louping ill virus with special reference to the effect of treatment with cyclophosphamide.
    Wood M
    Br J Exp Pathol; 1974 Feb; 55(1):56-63. PubMed ID: 4134208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congo (CON) strain. 3011.
    Am J Trop Med Hyg; 1970 Nov; 19(6):Suppl:1141-3. PubMed ID: 4992590
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies on interferon and virus production in young and old cell cultures prepared from ordinary and RIF-free chick embryos.
    Libíková H; Rajcáni J; Henslová E
    Acta Virol; 1969 Nov; 13(6):483-8. PubMed ID: 4391715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.